2025-09-22
Reporter: Katie McCabe Date: September 20, 2025
Last week, I closely followed and reported on three spot trading sessions of the “We Shall Never Surrender” profit plan. Born out of a financial shortfall, this plan, through the exceptional execution of the KKR team, has demonstrated remarkable capability—not only bridging the funding gap but also significantly boosting the morale and confidence of its participants.
In the first battle, the team leveraged precise market insights and decisive actions to secure an astonishing 203% profit, greatly uplifting the members’ spirits and laying a solid foundation for subsequent trades. In the second battle, despite heightened market volatility, the team remained steady and achieved a 112% profit, showcasing outstanding risk management skills. The third battle pushed the excitement to new heights, with the team concluding the week with a flawless 241% profit. Three successful trades in a single week not only skyrocketed the participants’ confidence but also injected boundless possibilities into the plan’s future.
As a journalist, I witnessed firsthand the professionalism and resilience the team displayed under pressure. KKR’s operational approach not only reflected a deep understanding of the market but also highlighted the power of teamwork. After each trade, the members showed unwavering faith in the plan, their passion and determination inspiring everyone involved.
The success of the “We Shall Never Surrender” profit plan is no fluke—it is the crystallization of the team’s wisdom and resolve. This is not just a financial victory but a profound rebuilding of confidence. I will continue to follow and report on the progress of this plan, offering readers an objective perspective on its developments. What surprises will this team bring in the future? Let’s wait and see!
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright2009-2020Fresh life